Abstract
Plasma from 33 patients at risk of multiple organ failure (MOF) after major trauma was tested for a priming effect on neutrophils, and for the presence of platelet-activating factor (PAF) activity and interleukin (IL) 8. Plasma sampled at 3, 6, 12 and 24 h after injury significantly primed normal neutrophils to release mean(s.e.m.) 1·26(0·19), 1·33(0·26), 1·04(0·14) and 0·86(0·13) nmol superoxide per min per 1·3 × 106 neutrophils respectively (P<0·05). Priming at 3 h after injury was inhibited by mean(s.e.m.) 63·8(7·0) per cent by the PAF antagonist, WEB 2170 (P<0·01). Mean(s.e.m.) plasma IL-8 was raised at 6 and 12 h after injury to 785(183) and 836(175) pg/ml (P<0·01). At 12 h after injury the plasma IL-8 level correlated directly with the number of units of red blood cells transfused (r=0·64, P<0·01), and was significantly higher in the group of six patients who developed MOF (P<0·05). These data suggest that after trauma the mediators PAF and IL-8 appear sequentially in the circulation, are potential mechanisms of circulating neutrophil priming, and that IL-8 may also be an early biochemical marker predicting the onset of MOF.
Contributor Information
A J Botha, Department of Surgery, Denver General Hospital, University of Colorado Health Sciences Center, Denver, Colorado, USA.
F A Moore, Department of Surgery, Denver General Hospital, University of Colorado Health Sciences Center, Denver, Colorado, USA.
E E Moore, Department of Surgery, Denver General Hospital, University of Colorado Health Sciences Center, Denver, Colorado, USA.
V M Peterson, Department of Surgery, Denver General Hospital, University of Colorado Health Sciences Center, Denver, Colorado, USA.
C C Silliman, Department of Surgery, Denver General Hospital, University of Colorado Health Sciences Center, Denver, Colorado, USA.
A W Goode, Department of Surgery, Denver General Hospital, University of Colorado Health Sciences Center, Denver, Colorado, USA.
References
- 1. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992; 268: 3452–5. [PubMed] [Google Scholar]
- 2. Botha AJ, Moore FA, Moore EE, Kim FJ, Banerjee A, Peterson VM. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery 1995; 118: 358–65. [DOI] [PubMed] [Google Scholar]
- 3. Botha AJ, Moore FA, Moore EE, Sauaia A, Banerjee A, Peterson VM. Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma 1995; 39: 412–17. [DOI] [PubMed] [Google Scholar]
- 4. Botha AJ, Moore FA, Moore EE, Fontes B, Banerjee A, Peterson VM. Postinjury neutrophil priming and activation states. Therapeutic challenges. Shock 1995; 3: 157–66. [DOI] [PubMed] [Google Scholar]
- 5. Botha AJ, Moore FA, Moore EE, Peterson VM, Goode AW. Increased CD11b receptor expression is an independent marker of early neutrophil priming. Br J Surg 1996; 83: 686 (Abstract). [Google Scholar]
- 6. Cuthbertson DP. Post-shock metabolic response. Lancet 1942; i: 433–7. [PubMed] [Google Scholar]
- 7. Fleck A, Myers M. Cellular aspects of clinical chemistry. In:Marshall WJ, Bangert SK, eds. Clinical Biochemistry. Metabolic and Clinical Aspects. New York: Churchill Livingstone, 1995: 717–38. [Google Scholar]
- 8. Murphy RC, Henson PM. Mediator network. Annales de Institut Pasteur-Immunologie 1985; 136D: 219–21. [DOI] [PubMed] [Google Scholar]
- 9. Stahl GL, Craft DV, Lento PH, Lefer AM. Detection of platelet-activating factor during traumatic shock. Circ Shock 1988; 26: 237–44. [PubMed] [Google Scholar]
- 10. Hoch RC, Rodriguez R, Manning T et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21: 839–45. [DOI] [PubMed] [Google Scholar]
- 11. Rodriguez JL, Miller CG, Garner WL et al. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993; 34: 684–95. [DOI] [PubMed] [Google Scholar]
- 12. Read RA, Moore EE, Moore FA, Carl VS, Banerjee A. Platelet-activating factor-induced polymorphonuclear neutrophil priming independent of CD11B adhesion. Surgery 1993; 114: 308–13. [PubMed] [Google Scholar]
- 13. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1992; 307: 97–101. [DOI] [PubMed] [Google Scholar]
- 14. Mozes T, Braquet P, Filep J. Platelet-activating factor: an endogenous mediator of mesenteric ischaemia-reperfusion-induced shock. Am J Physiol 1989; 257: R872–7. [DOI] [PubMed] [Google Scholar]
- 15. Kubes P, Ibbotson G, Russell J, Wallace JL, Granger DN. Role of platelet-activating factor in reperfusion-induced leucocyte adherence. Am J Physiol 1990; 259: G300–5. [DOI] [PubMed] [Google Scholar]
- 16. Koike K, Moore EE, Moore FA, Carl VS, Pitman JM, Banerjee A. Phospholipase A2 inhibition decouples lung injury from gut ischaemia-reperfusion. Surgery 1992; 112: 173–80. [PubMed] [Google Scholar]
- 17. Silliman CC, Johnson CA, Clay KL, Thurman GW, Ambruso DR. Compounds biologically similar to platelet activating factor are present in stored blood components. Lipids 1993; 28: 415–18. [DOI] [PubMed] [Google Scholar]
- 18. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994; 124: 684–94. [PMC free article] [PubMed] [Google Scholar]
- 19. Heddle NM, Klama L, Singer J et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331: 625–8. [DOI] [PubMed] [Google Scholar]
- 20. Stack G, Baril L, Napychank P, Snyder EL. Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion 1995; 35: 199–203. [DOI] [PubMed] [Google Scholar]
- 21. Kuhns DB, DeCarlo E, Hawk DM, Gallin JI. Dynamics of the cellular and humoral components of the inflammatory response elicited in skin blisters in humans. J Clin Invest 1992; 89: 1734–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Sauaia A, Moore FA, Moore EE, Haenel JB, Read RA, Lezotte DC. Early predictors of postinjury multiple organ failure. Arch Surg 1994; 129: 39–45. [DOI] [PubMed] [Google Scholar]
- 23. Boyum A, Lovhaug D, Tresland L, Nordlie EM. Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand J Immunol 1991; 34: 697–712. [DOI] [PubMed] [Google Scholar]
- 24. Guthrie LA, McPhail LC, Henson PM, Johnston RB. Priming of neutrophils for enhanced release of oxygen metabolites by lipopolysaccharide. J Exp Med 1984; 160: 1656–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Worthen GS, Seccombe JF, Clay KL, Guthrie LA, Johnston RB. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. J Immunol 1988; 140: 3553–9. [PubMed] [Google Scholar]
- 26. Cotran RS, Kumar V, Robbins SL, Schoen FJ. Inflammation and repair. In:Robbins. Pathologic Basis of Disease. Philadelphia, Pennsylvania: W B Saunders, 1994: 51–92. [Google Scholar]
- 27. Reilly PM, Bulkley GB. Vasoactive mediators and splanchnic perfusion. Crit Care Med 1993; 21: S55–68. [DOI] [PubMed] [Google Scholar]
- 28. Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci 1994; 307: 284–92. [DOI] [PubMed] [Google Scholar]
- 29. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995; 82: 582–7. [DOI] [PubMed] [Google Scholar]
- 30. Muyle L, Joos M, Wouters E, de Bock R, Peetermans ME. Increased tumor necrosis factor a (TNF-α), interleukin 1, and interleukin-6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF-α and IL-6 levels and febrile transfusion reactions. Transfusion 1993; 33: 195–9. [DOI] [PubMed] [Google Scholar]
- 31. Biffl W, Moore EE, Moore FA, Carl VS, Franciose RJ, Banerjee A. Interleukin-8 increases endothelial permeability independent of neutrophils. J Trauma 1995; 39: 98–102. [DOI] [PubMed] [Google Scholar]
- 32. Fontes B, Moore EE, Moore FA, Botha AJ, Carl V, Banerjee A. Gut ischaemia-reperfusion promotes sequestration of activated neutrophils in the lung but not in the liver. Surgical Forum 1994: 45: 104–6. [Google Scholar]
- 33. Marzi I, Buehren V, Schuettler A, Trentz O. Value of superoxide dismutase for prevention of multiple organ failure after multiple trauma. J Trauma 1993; 35: 110–20. [DOI] [PubMed] [Google Scholar]
- 34. Kingsnorth AN, Galloway SW, Formella LJ. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 1995; 82: 1414–20. [DOI] [PubMed] [Google Scholar]
- 35. Bates EJ, Harvey DP, Ferrante A. Inhibition of neutrophil respiratory burst and degranulation responses to platelet activating factor by antagonists WEB 2086, CV 6209 and CV 3988. International Archives of Allergy and Immunology 1992; 97: 50–6. [DOI] [PubMed] [Google Scholar]
- 36. Grino JM. BN 52120: a platelet activating factor antagonist for preventing post-transplant renal failure. Ann Intern Med 1994; 121: 345–7. [DOI] [PubMed] [Google Scholar]
- 37. Hoffmann TF, Leiderer R, Waldner H, Messmer K. Bradykinin antagonists HOE-140 and CP-0597diminish microcirculatory injury after ischaemia-reperfusion of the pancreas in rats. Br J Surg 1996; 83: 189–95. [PubMed] [Google Scholar]
- 38. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269: 1829–35. [PubMed] [Google Scholar]
- 39. Brand A. Passenger leukocytes, cytokines, and transfusion reactions. N Engl J Med 1994; 331: 670–1. [DOI] [PubMed] [Google Scholar]